Ondansetron for refractory pruritus of cholestasis Evidence in favor of therapeutic intervention on nociception
Milano, M.C.; Gutierrez, S.; Wainstein, R.; Colombato, L.A.
Gastroenterology 112(4 Suppl): A1333
1997
ISSN/ISBN: 0016-5085 Accession: 032640119
Full Text Article emailed within 1 workday: $29.90
Related References
Raderer, M.; Müller, C.; Scheithauer, W. 1994: Ondansetron for pruritus due to cholestasis New England Journal of Medicine 330(21): 1540Milano, C.; Fassio, E.; Gutierrez, S.; Santarelli, M.; Di Giovanni, R.; Colombato, L.A. 1998: Ondansetron for treatment of pruritus in cholestasis Hepatology 28(4 Part 2): 442A
Trioche, P.; Samuel, D.; Odièvre, M.; Labrune, P. 1996: Ondansetron for pruritus in child with chronic cholestasis European Journal of Pediatrics 155(11): 990
O'Donohue, J.W.; Pereira, S.P.; Ashdown, A.C.; Haigh, C.G.; Wilkinson, J.R.; Williams, R. 2005: A controlled trial of ondansetron in the pruritus of cholestasis Alimentary Pharmacology and Therapeutics 21(8): 1041-1045
O'donohue, J.W.; Haigh, C. 1997: Ondansetron in the treatment of the pruritus of cholestasis A randomised controlled trial Gastroenterology 112(4 Suppl): A1349
Yurdakul Ertan, H.; Özbakış Dengiz, G.ün.; Barut, F.; Yılmaz Ürün, Y.; Can, M.; Hussen, S.U.; Üstündağ, Y.üc. 2023: The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology 34(1): 62-72
Gingold, A.R.; Bergasa, N.V. 2003: The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis Life Sciences 73(21): 2741-2747
Sabine Zenker; Theda Schuh; Klaus Degitz 2003: Behandlung von Pruritus als Symptom von Hauterkrankungen mit dem Serotonin-Rezeptorantagonisten Ondansetron : Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron Jddg: Journal der Deutschen Dermatologischen Gesellschaft 1(9): 705-710
Ruiz Villaverde, R.; Sánchez Cano, D.; Villaverde Gutiérrez, C. 2006: Ondansetron. a satisfactory treatment for refractory palmo-plantar pruritus Actas Dermo-Sifiliograficas 97(10): 681-682
Fernando, G.; Preston, N. 2020: Refractory pruritus from malignant cholestasis: management Bmj Supportive and Palliative Care 2020
Al-Azzawi, H.; Patel, R.; Sood, G.; Kapoor, S. 2016: Plasmapheresis for Refractory Pruritus due to Drug-Induced Cholestasis Case Reports in Gastroenterology 10(3): 814-818
Gingold, A.R.; Weisen, R.; Bergasa, N.V. 2002: Cholestyramine induces cholecystokinin -mediated antiopiate neurotransmission and the cannabinoid agonist win 55, 212-2 incrreases nociception threshold in cholestatic rats Implications for the treatment of the pruritus of cholestasis Gastroenterology 123(1 Suppl): 64
Acalovschi, I.; Bodolea, C.; Slabu, L. 1996: Therapeutic effect of ondansetron and propofol on neuroaxial opioid-induced pruritus Acta Anaesthesiologica Scandinavica 40(Suppl 109): 222-223
Gillespie, D.A.; Vickers, C.R. 1993: Pruritus and cholestasis: therapeutic options Journal of Gastroenterology and Hepatology 8(2): 168-173
Rosales, A.; Muñoz, M.; Madrid, A.; Chocron, S.; Hernández, J.M.; Ariceta, G. 2018: Improvement of refractory pruritus after lipoprotein-apheresis in arthrogryposis-renal failure-cholestasis syndrome Journal of Clinical Apheresis 33(3): 401-403
Chkheidze, R.; Joseph, R.; Burner, J.; Matevosyan, K. 2018: Plasma exchange for the management of refractory pruritus of cholestasis: A report of three cases and review of literature Journal of Clinical Apheresis 33(3): 412-418
Bergasa, N.V.; Jones, E.A. 1995: The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids Gastroenterology 108(5): 1582-1588
Bergasa, N.V.; Jones, E.A. 1995: The pruritus of cholestasis : potential pathogenic and therapeutic implications of opioids Gastroenterology (New York, Ny 1943) 108(5): 1582-1588
Han, D.Woo.; Hong, S.Won.; Kwon, J-Young.; Lee, J.Woo.; Kim, K.Jun. 2007: Epidural ondansetron is more effective to prevent postoperative pruritus and nausea than intravenous ondansetron in elective cesarean delivery Acta Obstetricia et Gynecologica Scandinavica 86(6): 683-687
Han, D.W.; Hong, S.W.; Kwon, J.Y.; Lee, J.W.; Kim, K.J. 2008: Epidural Ondansetron is More Effective to Prevent Postoperative Pruritus and Nausea Than Intravenous Ondansetron in Elective Cesarean Delivery Obstetric Anesthesia Digest 28(1): 28-29